
    
      We included patients diagnosis of IBD (>18 yrs old) with indication of the use of
      thiopurine.Group A (intervention): AZA dose optimization by testing for NUDT15 R139C- testing
      results will be informed.Group B (control):AZA dose optimization according to standard
      guideline - testing results will not be informed.The participants will be followed for 9
      month. The incidence of adverse events and efficacy will be analyzed.
    
  